{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:22:20Z","timestamp":1794475340308,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled hypertension despite the use of \u22653 antihypertensive medication classes or controlled hypertension while treated with \u22654 antihypertensive medication classes. Although a high prevalence of aTRH has been reported, few data are available on its association with cardiovascular and renal outcomes. We analyzed data on 14 684 Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants to determine the association between aTRH (n=1870) with coronary heart disease, stroke, all-cause mortality, heart failure, peripheral artery disease, and end-stage renal disease. We defined aTRH as blood pressure not at goal (systolic\/diastolic blood pressure \u2265140\/90 mm Hg) while taking \u22653 classes of antihypertensive medication or taking \u22654 classes of antihypertensive medication with blood pressure at goal during the year 2 ALLHAT study visit (1996\u20132000). Use of a diuretic was not required to meet the definition of aTRH. Follow-up occurred through 2002. The multivariable adjusted hazard ratios (95% confidence intervals) comparing participants with versus without aTRH were as follows: coronary heart disease (1.44 [1.18\u20131.76]), stroke (1.57 [1.18\u20132.08]), all-cause mortality (1.30 [1.11\u20131.52]), heart failure (1.88 [1.52\u20132.34]), peripheral artery disease (1.23 [0.85\u20131.79]), and end-stage renal disease (1.95 [1.11\u20133.41]). aTRH was also associated with the pooled outcomes of combined coronary heart disease (hazard ratio, 1.47; 95% confidence interval, 1.26\u20131.71) and combined cardiovascular disease (hazard ratio, 1.46; 95% confidence interval, 1.29\u20131.64). These results demonstrate that aTRH increases the risk for cardiovascular disease and end-stage renal disease. Studies are needed to identify approaches to prevent aTRH and reduce risk for adverse outcomes among individuals with aTRH.<\/jats:p>","DOI":"10.1161\/hypertensionaha.114.03850","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T03:57:41Z","timestamp":1407211061000},"page":"1012-1021","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":218,"title":["Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease"],"prefix":"10.1161","volume":"64","author":[{"given":"Paul","family":"Muntner","sequence":"first","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cushman","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Calhoun","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Pressel","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Black","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Kostis","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Probstfield","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Whelton","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14739-3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70312-1"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.189141"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.030189"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2012.00690.x"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00037-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1967"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.8.936"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1595"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.111.068064"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs368"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.07.038"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamainternmed.857"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2012.48"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000259805.18468.8c"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-007-0066-7"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410050036006"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90878-9"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90944-Z"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62039-9"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.163014"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.114.03850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:53:49Z","timestamp":1715594029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.114.03850"}},"subtitle":["Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.114.03850"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.114.03850","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"2014-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}